Monitor for rapid share price decline as the conversion mechanism creates downward pressure; watch for registration statement filing which will enable resale of conversion shares; assess whether this financing indicates cash flow distress given the high-cost terms
Price Chart
Executive Summary
CERO Therapeutics raised $750,000 through a convertible promissory note with a principal of $937,500, bearing 10% interest and maturing August 6, 2027. The note is convertible into common stock at a discount (80% of the 5 lowest intraday prices over 20 days) or $0.05, whichever is lower, creating immediate dilution risk and increasing leverage.
Key Financial Metrics
Key Facts
- Raised $750,000 in exchange for a convertible note with $937,500 principal (25% premium)
- Note bears 10% annual interest and matures in August 2027
- Conversion price is the lesser of $0.05 or 80% of the 5 lowest intraday prices over 20 days prior to conversion
- Company must file registration statement for resale of conversion shares
- Unregistered private placement to accredited investor under Rule 506(b)
Financial Impact
$750,000 in new debt with significant dilution risk due to discount conversion and 25% premium
Risk Factors
- Significant dilution from discount-based conversion formula
- High interest rate (10%) increases financial burden
- Potential for death spiral financing if share price declines
- Registration requirement may flood market with new shares
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-025817 |
| Document: 0001213900-26-025817-index-headers.html | 0001213900-26-025817 |
| Document: 0001213900-26-025817-index.html | 0001213900-26-025817 |
| Document: 0001213900-26-025817.txt | 0001213900-26-025817 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | 8-K | $0.0120 $0.0105 | ▲ +12.50% | ▲ +13.68% | $0.0110 (+8.33%) |
Jul 13, 2026 11w ago | 25-NSE | $0.0150 $0.0100 | ▲ +33.33% | ▲ +36.52% | $0.0110 (+26.67%) |
Jun 26, 2026 14w ago | 8-K | $0.0110 $0.009700 | ▲ +11.82% | ▲ +11.56% | $0.0110 (+0.00%) |
Mar 11, 2026 29w ago | 8-K | $0.0350 $0.0340 | ▲ +2.86% | ▲ +3.38% | $0.0110 (+68.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access